Genetic Variation Putatively Associated with <i>Mycobacterium tuberculosis</i> Resistance to Perchlozone, a New Thiosemicarbazone: Clues from Whole Genome Sequencing and Implications for Treatment of Multidrug-Resistant Tuberculosis
Perchlozone ([PCZ] 4-thioureido-iminomethylpyridinium perchlorate) is a new thiosemicarbazone approved for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Russia and some other countries. The <i>ethA</i> and <i>hadABC</i> mutations may confer PCZ resistance. At...
Saved in:
Main Authors: | Igor Mokrousov (Author), Anna Vyazovaya (Author), Gulnora Akhmedova (Author), Natalia Solovieva (Author), Eugeni Turkin (Author), Viacheslav Zhuravlev (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perchlozone Resistance in Clinical Isolates of <i>Mycobacterium tuberculosis</i>
by: Anastasia Ushtanit, et al.
Published: (2023) -
Molecular Insight into <em>Mycobacterium tuberculosis</em> Resistance to Nitrofuranyl Amides Gained through Metagenomics-like Analysis of Spontaneous Mutants
by: Igor Mokrousov, et al.
Published: (2022) -
Genomic Variations in Drug Resistant <i>Mycobacterium tuberculosis</i> Strains Collected from Patients with Different Localization of Infection
by: Ekaterina Chernyaeva, et al.
Published: (2020) -
Characterization of Mutations Associated with Streptomycin Resistance in Multidrug-Resistant <i>Mycobacterium tuberculosis</i> in Zambia
by: Precious Bwalya, et al.
Published: (2021) -
QSAR Studies, Molecular Docking, Molecular Dynamics, Synthesis, and Biological Evaluation of Novel Quinolinone-Based Thiosemicarbazones against <i>Mycobacterium tuberculosis</i>
by: Jhesua Valencia, et al.
Published: (2022)